2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide

C131H260F4N28O17 — CID 161059298

IUPAC2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide
SMILESCC(C)N(C)C(=O)CN1CCOCC1.CC(C)NC(=O)C(C)(C)C1CCN(C)CC1.CC(C)NC(=O)C(C)N1CC(F)(F)C1.CC(C)NC(=O)C(C)N1CC(N)C1.CC(C)NC(=O)C(C)N1CC(O)C1.CC(C)NC(=O)CC1(C)CCN(C)CC1.CC(C)NC(=O)CC1CCCN(C)C1.CC(C)NC(=O)CC1CCN(C)C1.CC(C)NC(=O)CC1CCN(C)CC1.CC(C)NC(=O)CC1CCN(CC(F)F)CC1.CC(C)NC(=O)CN1CC(N)C1.CC(C)NC(=O)CN1CC(O)C1.CC(C)NC(=O)CN1CCOCC1
InChIInChI=1S/C13H26N2O.C12H22F2N2O.C12H24N2O.2C11H22N2O.C10H20N2O2.C10H20N2O.C9H16F2N2O.C9H19N3O.2C9H18N2O2.C8H17N3O.C8H16N2O2/c1-10(2)14-12(16)13(3,4)11-6-8-15(5)9-7-11;1-9(2)15-12(17)7-10-3-5-16(6-4-10)8-11(13)14;1-10(2)13-11(15)9-12(3)5-7-14(4)8-6-12;1-9(2)12-11(14)8-10-4-6-13(3)7-5-10;1-9(2)12-11(14)7-10-5-4-6-13(3)8-10;1-9(2)11(3)10(13)8-12-4-6-14-7-5-12;1-8(2)11-10(13)6-9-4-5-12(3)7-9;1-6(2)12-8(14)7(3)13-4-9(10,11)5-13;1-6(2)11-9(13)7(3)12-4-8(10)5-12;1-6(2)10-9(13)7(3)11-4-8(12)5-11;1-8(2)10-9(12)7-11-3-5-13-6-4-11;1-6(2)10-8(12)5-11-3-7(9)4-11;1-6(2)9-8(12)5-10-3-7(11)4-10/h10-11H,6-9H2,1-5H3,(H,14,16);9-11H,3-8H2,1-2H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);2*9-10H,4-8H2,1-3H3,(H,12,14);9H,4-8H2,1-3H3;8-9H,4-7H2,1-3H3,(H,11,13);6-7H,4-5H2,1-3H3,(H,12,14);6-8H,4-5,10H2,1-3H3,(H,11,13);6-8,12H,4-5H2,1-3H3,(H,10,13);8H,3-7H2,1-2H3,(H,10,12);6-7H,3-5,9H2,1-2H3,(H,10,12);6-7,11H,3-5H2,1-2H3,(H,9,12)
InChIKeyUDEKCWDERHZPAN-UHFFFAOYSA-N
MW2575.69 g/mol
LogP7.07
Rot. Bonds41

About 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide

2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide (PubChem CID 161059298) has the molecular formula C131H260F4N28O17 and a molecular weight of 2575.69 g/mol. Its IUPAC name is 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide.

Molecular Properties

Compound Name2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide
PubChem CID161059298
Molecular FormulaC131H260F4N28O17
Molecular Weight2575.69 g/mol
Exact Mass2574.03
IUPAC Name2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide
SMILESCC(C)N(C)C(=O)CN1CCOCC1.CC(C)NC(=O)C(C)(C)C1CCN(C)CC1.CC(C)NC(=O)C(C)N1CC(F)(F)C1.CC(C)NC(=O)C(C)N1CC(N)C1.CC(C)NC(=O)C(C)N1CC(O)C1.CC(C)NC(=O)CC1(C)CCN(C)CC1.CC(C)NC(=O)CC1CCCN(C)C1.CC(C)NC(=O)CC1CCN(C)C1.CC(C)NC(=O)CC1CCN(C)CC1.CC(C)NC(=O)CC1CCN(CC(F)F)CC1.CC(C)NC(=O)CN1CC(N)C1.CC(C)NC(=O)CN1CC(O)C1.CC(C)NC(=O)CN1CCOCC1
InChIInChI=1S/C13H26N2O.C12H22F2N2O.C12H24N2O.2C11H22N2O.C10H20N2O2.C10H20N2O.C9H16F2N2O.C9H19N3O.2C9H18N2O2.C8H17N3O.C8H16N2O2/c1-10(2)14-12(16)13(3,4)11-6-8-15(5)9-7-11;1-9(2)15-12(17)7-10-3-5-16(6-4-10)8-11(13)14;1-10(2)13-11(15)9-12(3)5-7-14(4)8-6-12;1-9(2)12-11(14)8-10-4-6-13(3)7-5-10;1-9(2)12-11(14)7-10-5-4-6-13(3)8-10;1-9(2)11(3)10(13)8-12-4-6-14-7-5-12;1-8(2)11-10(13)6-9-4-5-12(3)7-9;1-6(2)12-8(14)7(3)13-4-9(10,11)5-13;1-6(2)11-9(13)7(3)12-4-8(10)5-12;1-6(2)10-9(13)7(3)11-4-8(12)5-11;1-8(2)10-9(12)7-11-3-5-13-6-4-11;1-6(2)10-8(12)5-11-3-7(9)4-11;1-6(2)9-8(12)5-10-3-7(11)4-10/h10-11H,6-9H2,1-5H3,(H,14,16);9-11H,3-8H2,1-2H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);2*9-10H,4-8H2,1-3H3,(H,12,14);9H,4-8H2,1-3H3;8-9H,4-7H2,1-3H3,(H,11,13);6-7H,4-5H2,1-3H3,(H,12,14);6-8H,4-5,10H2,1-3H3,(H,11,13);6-8,12H,4-5H2,1-3H3,(H,10,13);8H,3-7H2,1-2H3,(H,10,12);6-7H,3-5,9H2,1-2H3,(H,10,12);6-7,11H,3-5H2,1-2H3,(H,9,12)
InChIKeyUDEKCWDERHZPAN-UHFFFAOYSA-N
XLogP7.07
TPSA522.59 Ų
H-Bond Donors16
H-Bond Acceptors32
Rotatable Bonds41
Heavy Atoms180
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002575.69
LogP ≤ 57.07
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1032

Analyze 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide
CID 158096073
4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[3-methyl-1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide
CID 158157819
N-[2-(diethylamino)ethyl]-N-ethyl-3-methylbutanamide;N,N-diethyl-3-methylbutan-1-amine;2,2-difluoro-3-methylbutane;4-(2,3-dimethylbutyl)morpholine;(3S,5R)-3,5-dimethyl-1-(2-methylpropyl)piperidine;2,3-dimethyl-1-morpholin-4-ylbutan-1-one;3-methoxy-1-(3-methylbutan-2-yl)azetidine;2-methylbutane;4-(3-methylbutyl)morpholine;1-(3-methylbutyl)piperazine;3-methyl-1-morpholin-4-ylbutan-1-one;3-methyl-N-(3-morpholin-4-ylpropyl)butanamide;2-methylpentane;3-methyl-N-propan-2-ylbutan-1-amine;3-methyl-1-(4-propan-2-ylpiperazin-1-yl)butan-1-one;1-(2-methylpropyl)azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;3-methyl-N-propylbutan-1-amine;N,N,2-trimethylpropan-1-amine
CID 158177439
N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium
CID 158227845
1-tert-butyl-4-(2-methylpropyl)piperazine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide
CID 158397394
tris(2-(3,3-difluoro-1-methylpiperidin-4-yl)-N-propan-2-ylacetamide);tris(2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide);tris(2-(4-fluoro-1-methylpiperidin-4-yl)-N-propan-2-ylacetamide);bis(2-hydroxy-3-methyl-N-propan-2-ylbutanamide);bis(2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide);2-morpholin-4-yl-N-propan-2-ylacetamide;bis(2-piperidin-1-yl-N-propan-2-ylacetamide)
CID 159653205
4-(azetidin-1-yl)-3,3-difluoro-1-(2-methylpropyl)piperidine;1-tert-butyl-4-(2-methylpropyl)piperazine;(2R)-2-hydroxy-1-[4-(2-methylpropyl)piperazin-1-yl]propan-1-one;7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one;[4-methyl-1-(2-methylpropyl)piperidin-4-yl]methanol;2-methyl-2-[1-(2-methylpropyl)piperidin-4-yl]propan-1-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-[1-(2-methylpropyl)piperidin-4-yl]azetidin-3-ol;1-[1-(2-methylpropyl)piperidin-4-yl]ethanol;1-[1-(2-methylpropyl)piperidin-4-yl]pyrrolidin-3-ol;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine
CID 160869396
2-cyclobutyl-N-propan-2-ylacetamide;2-(3-fluoro-3-methylazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-(1-methylazetidin-3-yl)-N-propan-2-ylacetamide;bis(2-(3-methylazetidin-1-yl)-N-propan-2-ylacetamide);2-(3-methylazetidin-1-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide
CID 161562399

Frequently Asked Questions

What is the IUPAC name of 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide?
The IUPAC name of 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide (CID 161059298) is 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide.
What is the SMILES notation for 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide?
The canonical SMILES for 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide is CC(C)N(C)C(=O)CN1CCOCC1.CC(C)NC(=O)C(C)(C)C1CCN(C)CC1.CC(C)NC(=O)C(C)N1CC(F)(F)C1.CC(C)NC(=O)C(C)N1CC(N)C1.CC(C)NC(=O)C(C)N1CC(O)C1.CC(C)NC(=O)CC1(C)CCN(C)CC1.CC(C)NC(=O)CC1CCCN(C)C1.CC(C)NC(=O)CC1CCN(C)C1.CC(C)NC(=O)CC1CCN(C)CC1.CC(C)NC(=O)CC1CCN(CC(F)F)CC1.CC(C)NC(=O)CN1CC(N)C1.CC(C)NC(=O)CN1CC(O)C1.CC(C)NC(=O)CN1CCOCC1.
What is the InChIKey of 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide?
The InChIKey is UDEKCWDERHZPAN-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H26N2O.C12H22F2N2O.C12H24N2O.2C11H22N2O.C10H20N2O2.C10H20N2O.C9H16F2N2O.C9H19N3O.2C9H18N2O2.C8H17N3O.C8H16N2O2/c1-10(2)14-12(16)13(3,4)11-6-8-15(5)9-7-11;1-9(2)15-12(17)7-10-3-5-16(6-4-10)8-11(13)14;1-10(2)13-11(15)9-12(3)5-7-14(4)8-6-12;1-9(2)12-11(14)8-10-4-6-13(3)7-5-10;1-9(2)12-11(14)7-10-5-4-6-13(3)8-10;1-9(2)11(3)10(13)8-12-4-6-14-7-5-12;1-8(2)11-10(13)6-9-4-5-12(3)7-9;1-6(2)12-8(14)7(3)13-4-9(10,11)5-13;1-6(2)11-9(13)7(3)12-4-8(10)5-12;1-6(2)10-9(13)7(3)11-4-8(12)5-11;1-8(2)10-9(12)7-11-3-5-13-6-4-11;1-6(2)10-8(12)5-11-3-7(9)4-11;1-6(2)9-8(12)5-10-3-7(11)4-10/h10-11H,6-9H2,1-5H3,(H,14,16);9-11H,3-8H2,1-2H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);2*9-10H,4-8H2,1-3H3,(H,12,14);9H,4-8H2,1-3H3;8-9H,4-7H2,1-3H3,(H,11,13);6-7H,4-5H2,1-3H3,(H,12,14);6-8H,4-5,10H2,1-3H3,(H,11,13);6-8,12H,4-5H2,1-3H3,(H,10,13);8H,3-7H2,1-2H3,(H,10,12);6-7H,3-5,9H2,1-2H3,(H,10,12);6-7,11H,3-5H2,1-2H3,(H,9,12).
What are the key properties of 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide?
2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide has a molecular weight of 2575.69 g/mol, XLogP of 7.07, 41 rotatable bonds, 16 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-aminoazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-aminoazetidin-1-yl)-N-propan-2-ylpropanamide;2-(3,3-difluoroazetidin-1-yl)-N-propan-2-ylpropanamide;2-[1-(2,2-difluoroethyl)piperidin-4-yl]-N-propan-2-ylacetamide;2-(1,4-dimethylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylacetamide;2-(3-hydroxyazetidin-1-yl)-N-propan-2-ylpropanamide;2-methyl-2-(1-methylpiperidin-4-yl)-N-propan-2-ylpropanamide;N-methyl-2-morpholin-4-yl-N-propan-2-ylacetamide;2-(1-methylpiperidin-3-yl)-N-propan-2-ylacetamide;2-(1-methylpiperidin-4-yl)-N-propan-2-ylacetamide;2-(1-methylpyrrolidin-3-yl)-N-propan-2-ylacetamide;2-morpholin-4-yl-N-propan-2-ylacetamide is sourced from PubChem (CID 161059298), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).